FR7072M - - Google Patents

Info

Publication number
FR7072M
FR7072M FR122668A FR122668A FR7072M FR 7072 M FR7072 M FR 7072M FR 122668 A FR122668 A FR 122668A FR 122668 A FR122668 A FR 122668A FR 7072 M FR7072 M FR 7072M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR122668A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR112738A external-priority patent/FR1530087A/fr
Application filed filed Critical
Priority to FR122668A priority Critical patent/FR7072M/fr
Application granted granted Critical
Publication of FR7072M publication Critical patent/FR7072M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR122668A 1966-06-30 1967-09-28 Expired FR7072M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR122668A FR7072M (fr) 1966-06-30 1967-09-28

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEB0087792 1966-06-30
FR112738A FR1530087A (fr) 1966-06-30 1967-06-30 Procédés pour fabriquer de nouvelles 2-benzylamino-imidazolines-(2)
FR122668A FR7072M (fr) 1966-06-30 1967-09-28

Publications (1)

Publication Number Publication Date
FR7072M true FR7072M (fr) 1969-06-30

Family

ID=6983950

Family Applications (1)

Application Number Title Priority Date Filing Date
FR122668A Expired FR7072M (fr) 1966-06-30 1967-09-28

Country Status (6)

Country Link
BE (1) BE700802A (fr)
CH (1) CH486466A (fr)
ES (1) ES342394A1 (fr)
FR (1) FR7072M (fr)
GB (1) GB1174988A (fr)
NL (1) NL6708160A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152052A1 (fr) * 2008-06-09 2009-12-17 Allergan, Inc. Procédés de traitement d'affections à médiation alpha-adrénergique
WO2009140204A3 (fr) * 2008-05-16 2010-01-07 Allergan, Inc. Agents sélectifs des récepteurs alpha 2 adrénergiques et leurs méthodes d'utilisation
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009140204A3 (fr) * 2008-05-16 2010-01-07 Allergan, Inc. Agents sélectifs des récepteurs alpha 2 adrénergiques et leurs méthodes d'utilisation
EP2319511A3 (fr) * 2008-05-16 2012-08-15 Allergan, Inc. Agents sélectifs des récepteurs adrénergiques de sous-type alpha 2 et leurs méthodes d'utilisation
US8486985B2 (en) 2008-05-16 2013-07-16 Allergan, Inc. Selective subtype alpha 2 adrenergic agents and methods for use thereof
WO2009152052A1 (fr) * 2008-06-09 2009-12-17 Allergan, Inc. Procédés de traitement d'affections à médiation alpha-adrénergique
EP2377534A1 (fr) * 2008-06-09 2011-10-19 Allergan, Inc. Procédé pour le traitement d'états à médiation alpha-adrénergique
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP2932968A1 (fr) * 2008-06-09 2015-10-21 Allergan, Inc. Composé pour le traitement d'états à médiation alpha-adrénergique

Also Published As

Publication number Publication date
BE700802A (fr) 1968-01-02
NL6708160A (fr) 1968-01-02
ES342394A1 (es) 1968-09-16
CH486466A (de) 1970-02-28
GB1174988A (en) 1969-12-17

Similar Documents

Publication Publication Date Title
FR7072M (fr)
AU5917865A (fr)
AU1144366A (fr)
AU6703465A (fr)
AU6597365A (fr)
AU612166A (fr)
AU5895065A (fr)
BE675139A (fr)
BE674792A (fr)
BE693937A (fr)
BE693908A (fr)
BE693153A (fr)
BE692826A (fr)
BE692822A (fr)
BE692771A (fr)
BE692647A (fr)
BE692579A (fr)
BE692539A (fr)
BE692331A (fr)
BE690950A (fr)
BE685480A (fr)
BE677984A (fr)
BE675173A (fr)
BE694638A (fr)
BE675084A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse